A thyroid medication recall that began quietly this summer now carries the most serious warning federal regulators can issue. On Sept. 22, the U.S. Food and Drug Administration classified the recall of one lot of Vitruvias Therapeutics thyroid tablets as Class I, a label reserved for products with a reasonable chance of causing serious health […]

The post1,900 bottles of thyroid pills trigger FDA’s top alertappeared first onRolling Out.